| 1 |
28107479 | Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate. | 2017 |
3 |
| 2 |
25681335 | Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells. | 2015 Mar 15 |
7 |
| 3 |
21224428 | Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL. | 2011 Feb |
5 |
| 4 |
17709797 | Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma. | 2007 Sep 20 |
2 |
| 5 |
16219794 | Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. | 2006 Mar 15 |
4 |